about
The Cryptococcus neoformans capsule: a sword and a shield.Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable.UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37 degrees C and for capsule biosynthesisMobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.Properties of various Rho1 mutant alleles of Cryptococcus neoformans.How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.Cryptococcus neoformans mediator protein Ssn8 negatively regulates diverse physiological processes and is required for virulenceEarly induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.Identification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans.KRE genes are required for beta-1,6-glucan synthesis, maintenance of capsule architecture and cell wall protein anchoring in Cryptococcus neoformansGlucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.Caspofungin: first approved agent in a new class of antifungals.Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.A yeast under cover: the capsule of Cryptococcus neoformans.Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated formBinding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans.Chronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformansRole of protein O-mannosyltransferase Pmt4 in the morphogenesis and virulence of Cryptococcus neoformansA glycosylphosphatidylinositol anchor is required for membrane localization but dispensable for cell wall association of chitin deacetylase 2 in Cryptococcus neoformans.Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence.Extracellular vesicles from Paracoccidioides pathogenic species transport polysaccharide and expose ligands for DC-SIGN receptors.Characterization of Lipids and Proteins Associated to the Cell Wall of the Acapsular Mutant Cryptococcus neoformans Cap 67.Insight into the distribution of molecular weights and higher-order structure of hyaluronans and some beta-(1 --> 3)-glucans by size exclusion chromatography.Galactoxylomannans of Cryptococcus neoformans.Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans.Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans.Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules.Role of the alpha-glucanase Agn1p in fission-yeast cell separationActivation of the complement system by pathogenic fungi.Identification of N-acetylneuraminic acid and its 9-O-acetylated derivative on the cell surface of Cryptococcus neoformans: influence on fungal phagocytosis.Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival.Polysaccharide antigens of the capsule of Cryptococcus neoformans.Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans.Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans.Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.Compounds active against cell walls of medically important fungi
P2860
Q24619875-4583C672-8DA0-4BDA-99BC-A993F3E64053Q24625384-DA8BB4E5-C8EA-4F5A-9D7F-5209C92E21A3Q28367886-5E7BB87A-0E22-4442-9579-9F9747023449Q28379217-9E82B011-7840-415F-8EAC-FC419DC68725Q33522882-B84C0B90-8B3A-49FD-ABB1-DA34508B62C7Q33560489-C86E8C74-9629-4D61-8296-214B5F1AD54AQ33616470-7FE8BDC5-288B-4AE1-8982-706849A829B2Q33791723-497151FE-B56D-4F73-BB1F-417CF9157CB3Q33894565-74043AED-06E4-4FA5-A64E-3A0F1416EB0BQ33895191-437AAB0E-62E9-4C2C-9436-7B0DDFD49A0BQ34003199-DD6A1DF9-2CA2-4450-8093-6CD206FD8320Q34229854-3918123E-43B7-482A-8B58-848A960662D4Q34265597-5B0583BF-5059-4CBC-B80A-620EE8AC1F18Q34775729-8D11B194-11D1-4F21-BD01-D284381E6090Q35124726-3DC26A78-A897-4595-8A54-D81A4D437EECQ35193330-29A88815-BD0C-4F63-8760-2C2AFAD12283Q35197202-3173EFEA-FEB2-48D1-9566-27C0BF7D273DQ35422948-EA7ABF2A-557B-484D-AA9A-4F4002DB15FCQ35435044-2B6EA272-23BA-42F9-963B-A6A4F98DB2AFQ35513657-C4F89548-96C7-4DC2-A20A-CDD8CF266091Q35598044-00FBF201-CF00-4751-ACB7-823ECFC20D18Q35636471-CED0D842-0933-4474-BB01-8225BAAFDBE8Q35759756-ECED5934-E363-4320-8C21-53D1AA60B9BCQ35781610-F6CD45F6-6AF7-42F8-BE79-7D3E1A18880EQ36099158-BB7E0024-7B45-4989-A9B7-B3FB3E5DE161Q36208572-E3C554F6-5DB3-49E1-B7B6-69286EF40EDCQ36833200-2A976375-688B-4986-960D-1BA0380A92EAQ36956261-417FF19F-7473-4500-A8C1-7C839933D4A2Q36958708-AB65E3B7-3D39-4C69-BA8B-64A58B640494Q36967835-E32F9B6F-33C6-4EC1-B3F0-A8E99B2AA049Q37078933-5F8CE09A-A46A-4D1A-850A-31D5DF08B9FEQ39285009-24D3D537-8FDB-4BED-9A16-D8F89A018798Q39820650-DCD1D7B8-14D6-4E86-8408-8ECFBBDA8EC8Q39831643-9DCCB809-776C-44A0-812E-DEB5B52FEF1DQ39849808-BECB97E6-4D49-4B38-8A0E-6B6308BBC79AQ39859915-FD5B63CE-E54B-46CC-850B-1203EC54D2D5Q40148722-C8C2B33F-84B1-4415-8BD1-F277913FD6B8Q40384960-E18AD627-57F8-48B6-8722-6C4337E4ED96Q40582548-AAC3AA60-7E1F-4C66-8728-CAF03D6B52A5Q40889532-5E52B3CE-C8C4-41C9-868C-E34178CB1470
P2860
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Cell-wall glucans of Cryptococcus neoformans Cap 67.
@ast
Cell-wall glucans of Cryptococcus neoformans Cap 67.
@en
Cell-wall glucans of Cryptococcus neoformans Cap 67.
@nl
type
label
Cell-wall glucans of Cryptococcus neoformans Cap 67.
@ast
Cell-wall glucans of Cryptococcus neoformans Cap 67.
@en
Cell-wall glucans of Cryptococcus neoformans Cap 67.
@nl
prefLabel
Cell-wall glucans of Cryptococcus neoformans Cap 67.
@ast
Cell-wall glucans of Cryptococcus neoformans Cap 67.
@en
Cell-wall glucans of Cryptococcus neoformans Cap 67.
@nl
P2093
P1476
Cell-wall glucans of Cryptococcus neoformans Cap 67.
@en
P2093
P356
10.1016/0008-6215(90)84273-W
P577
1990-04-01T00:00:00Z